Statera BioPharma (FRA:7CB) Other Current Payables: €0.00 Mil (As of Sep. 2022)


FRA:7CB Statera BioPharma Inc FRA:7CB
20 GF Score
Price €2.61
View Full Analysis

What is Statera BioPharma Other Current Payables?

Statera BioPharma FRA:7CB 20 Other Current Payables is €0.00 Mil as of Sep. 2022. GuruFocus rates FRA:7CB with a GF Score™ of 20/100.

Statera BioPharma's Other Current Payables for the quarter that ended in Sep. 2022 was €0.00 Mil.

Statera BioPharma Other Current Payables Related Terms

Statera BioPharma Other Current Payables Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Other Current Payables Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Other Current Payables
0.00 0.00 0.00

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.17 0.00 0.00 0.00 0.00
FRA:7CB
20GF Score
Statera BioPharma Inc FRA:7CB
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Statera BioPharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €0.00 Mil mean?
Statera BioPharma (FRA:7CB) has a Other Current Payables of €0.00 Mil as of Sep. 2022. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's Other Current Payables too high?
Statera BioPharma's current Other Current Payables is €0.00 Mil. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's Other Current Payables compare to NRBO and PALI?
Statera BioPharma's Other Current Payables of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current Other Current Payables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (FRA:7CB) has a current Other Current Payables of €0.00 Mil. The current Other Current Payables is €0.00 Mil. Statera BioPharma's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Statera BioPharma (FRA:7CB), the current Other Current Payables is €0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.
20GF Score

Get the complete analysis for FRA:7CB

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.61
Price